INVITATION to a Novartis ESG Conference Call
September 04, 2015 09:36 ET
|
Novartis Investor Relations
INVITATION to a Novartis ESG conference call We would like to invite you to a conference call and audiocast on the topic of Novartis approach to Corporate Responsibility, including...
Invitation to a Sell-Side Dinner in London on October 28, 2015
September 01, 2015 05:34 ET
|
Novartis Investor Relations
INVITATION to a Sell-Side Dinner onOctober 28, 2015 - 18.45 h GMT We are delighted to invite you to our sell-side dinner on Wednesday, October 28, 2015. This event will be hosted by Harry Kirsch....
GILENYA Update
August 17, 2015 12:00 ET
|
Novartis Investor Relations
Novartis has been informed of a third case of progressive multifocal leukoencephalopathy (PML) in a patient with relapsing MS (RMS) treated with Gilenya without prior exposure to natalizumab...
PRESENTATION NOW LIVE ON THE WEB - Novartis Q2 2015 Results, July 21, 2015 - 14:00 CEST
July 21, 2015 05:16 ET
|
Novartis Investor Relations
Invitation to a conference call and live audio webcast Novartis Q2 2015 ResultsJuly 21, 2015 - 14:00 CEST We are pleased to invite you to a conference call and live audio webcastfor the Novartis...
REMINDER - Novartis Q2 2015 Results, July 21, 2015 - 14:00 CEST
July 16, 2015 02:29 ET
|
Novartis Investor Relations
Invitation to a conference call and live audio webcast Novartis Q2 2015 ResultsJuly 21, 2015 - 14:00 CEST We are pleased to invite you to a conference call and live audio webcastfor the Novartis...
INVITATION - Novartis Q2 2015 Results, July 21, 2015 - 14:00 CEST
July 13, 2015 04:15 ET
|
Novartis Investor Relations
Invitation to a conference call and live audio webcast Novartis Q2 2015 ResultsJuly 21, 2015 - 14:00 CEST We are pleased to invite you to a conference call and live audio webcastfor the Novartis...
REMINDER - Invitation to a conference call - Entresto(TM) US approval - July 08, 2015 - 07:30 am CEST
July 08, 2015 01:05 ET
|
Novartis Investor Relations
Invitation to a conference call EntrestoTM US approvalJuly 08, 2015 - 07:30 am CEST We are pleased to invite you to a conference call to discuss EntrestoTM (LCZ696) US approval. The call will...
Invitation to a conference call - Entresto(TM) US approval - July 08, 2015 - 07:30 am CEST
July 07, 2015 16:57 ET
|
Novartis Investor Relations
Invitation to a conference call EntrestoTM US approvalJuly 08, 2015 - 07:30 am CEST We are pleased to invite you to a conference call to discuss EntrestoTM (LCZ696) US approval. The call will...
GILENYA Update
June 05, 2015 09:02 ET
|
Novartis Investor Relations
Novartis has been informed of a patient with progressive multifocal leukoencephalopathy (PML). The patient had been diagnosed with ulcerative colitis (an autoimmune bowel disease) in 2011 and...
REMINDER - Meet Novartis Management, June 17-18, 2015 in Boston
April 27, 2015 04:53 ET
|
Novartis Investor Relations
INVITATION to "Meet Novartis Management" Event, June 17-18, 2015 in Boston We are pleased to invite you to our second "Meet Novartis Management" event, an investor and analyst meeting in Boston.It...